Summary
Novo Nordisks next-gen weight loss drug and Zepbound seem fairly equal to me, one expert says after release of new late-stage results for CagriSema.
Source: STAT
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
